HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Pan, Banzhou ^a   Chen, Dongqin ^a   Huang, Jiayuan ^a   Wang, Rui ^a   Feng, Bing ^a   Song, Haizhu ^a   Chen, Longbang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Autophagy; Chemoresistance; High mobility group box 1; Lung adenocarcinoma

Indexed keywords

BECLIN 1; CASPASE 3; DOCETAXEL; HIGH MOBILITY GROUP B1 PROTEIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; SHORT HAIRPIN RNA; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MEMBRANE PROTEIN; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TAXOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; MTT ASSAY; NOD SCID MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; BIOLOGICAL MODEL; CELL PROTECTION; CYTOSOL; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; GENE SILENCING; LUNG TUMOR; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROTEIN TRANSPORT; SCID MOUSE; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; CYTOPROTECTION; CYTOSOL; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; HMGB1 PROTEIN; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE, INBRED NOD; MICE, SCID; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TAXOIDS; TOR SERINE-THREONINE KINASES;

EID: 84905380519     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-165     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Gettinger S, Lynch T. A decade of advances in treatment for advanced non-small cell lung cancer. Clin Chest Med 2011, 32:839-851. 10.1016/j.ccm.2011.08.017, 22054890.
3. Uygun K, Aksu G, Cicin I, Karagol H, Kocak Z, Fayda M, Binici A, Uzunoglu F. The efficiency of single agent docetaxel in patients with platinum-refractory non-small cell lung carcinoma. Med Oncol 2008, 25:408-414. 10.1007/s12032-008-9055-1, 18320363.
4. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005, 5:726-734. 10.1038/nrc1692, 16148885.
5. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326. 10.1016/j.cell.2010.01.028, 2852113, 20144757.
6. Dikic I, Johansen T, Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res 2010, 70:3431-3434. 10.1158/0008-5472.CAN-09-4027, 20424122.
7. Livesey KM, Kang R, Vernon P, Buchser W, Loughran P, Watkins SC, Zhang L, Manfredi JJ, Zeh HJ, Li L, Lotze MT, Tang D. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res 2012, 72:1996-2005. 10.1158/0008-5472.CAN-11-2291, 3417120, 22345153.
8. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ, Lotze MT. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29:5299-5310. 10.1038/onc.2010.261, 2945431, 20622903.
9. Bell CW, Jiang W, Reich CF, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006, 291:C1318-C1325.
10. Leblanc PM, Doggett TA, Choi J, Hancock MA, Durocher Y, Frank F, Nagar B, Ferguson TA, Saleh M. An immunogenic peptide in the a-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor. J Biol Chem 2014, 289:7777-7786. 10.1074/jbc.M113.541474, 24474694.
11. Brezniceanu ML, Volp K, Bosser S, Solbach C, Lichter P, Joos S, Zornig M. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J 2003, 17:1295-1297.
12. Meyer A, Staratschek-Jox A, Springwald A, Wenk H, Wolf J, Wickenhauser C, Bullerdiek J. Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1. Leuk Lymphoma 2008, 49:1184-1189. 10.1080/10428190802064909, 18569640.
13. Lee H, Park M, Shin N, Kim G, Kim YG, Shin JS, Kim H. High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem Biophys Res Commun 2012, 424:321-326. 10.1016/j.bbrc.2012.06.116, 22750245.
14. Zhan Z, Li Q, Wu P, Ye Y, Tseng HY, Zhang L, Zhang XD. Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1. Autophagy 2012, 8:109-121. 10.4161/auto.8.1.18319, 22108005.
15. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, Al-Younes HM, Al-Zeer MA, Albert ML, Albin RL, Alegre-Abarrategui J, Aleo MF, Alirezaei M, Almasan A, Almonte-Becerril M, Amano A, Amaravadi R, Amarnath S, Amer AO, Andrieu-Avadie N, Anantharam V, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544. 10.4161/auto.19496, 3404883, 22966490.
16. Wallington-Beddoe CT, Hewson J, Bradstock KF, Bendall LJ. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. Autophagy 2011, 7:707-715. 10.4161/auto.7.7.15154, 21460633.
17. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996, 315(Pt 1):21-24. 1217173, 8670109.
18. Ling YH, Aracil M, Zou Y, Yuan Z, Lu B, Jimeno J, Cuervo AM, Perez-Soler R. PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase. Clin Cancer Res 2011, 17:5353-5366. 10.1158/1078-0432.CCR-10-1948, 21690574.
19. Wang M, Yu T, Zhu C, Sun H, Qiu Y, Zhu X, Li J. Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells. Nutr Cancer 2014, 66:435-440. 10.1080/01635581.2013.878738, 24579778.
20. Gulati P, Thomas G. Nutrient sensing in the mTOR/S6K1 signalling pathway. Biochem Soc Trans 2007, 35:236-238. 10.1042/BST0350236, 17371247.
21. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006, 124:471-484. 10.1016/j.cell.2006.01.016, 16469695.
22. Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, Kondo S. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 2005, 65:3336-3346.
23. Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010, 12:814-822. 10.1038/ncb0910-814, 3616322, 20811353.
24. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009, 43:67-93. 10.1146/annurev-genet-102808-114910, 2831538, 19653858.
25. Foo J, Michor F. Evolution of acquired resistance to anti-cancer therapy. J Theor Biol 2014, 355C:10-20.
26. Lai PF, Cheng CF, Lin H, Tseng TL, Chen HH, Chen SH. ATF3 protects against LPS-induced inflammation in mice via inhibiting HMGB1 expression. Evid Based Complement Altern Med 2013, 2013:716481.
27. Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P, Bierhaus A, Lotze MT, Zeh HJ. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2010, 17:666-676. 10.1038/cdd.2009.149, 3417122, 19834494.
28. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ, Lotze MT. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010, 190:881-892. 10.1083/jcb.200911078, 2935581, 20819940.
29. Perez-Carrion MD, Cena V. Knocking down HMGB1 using dendrimer-delivered siRNA unveils its key role in nmda-induced autophagy in rat cortical neurons. Pharm Res 2013, 30:2584-2595. 10.1007/s11095-013-1049-9, 23604926.
30. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
31. Yang L, Yu Y, Kang R, Yang M, Xie M, Wang Z, Tang D, Zhao M, Liu L, Zhang H, Cao L. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk Lymphoma 2012, 53:315-322. 10.3109/10428194.2011.616962, 21864037.
32. He Q, Liang CH, Lippard SJ. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci U S A 2000, 97:5768-5772. 10.1073/pnas.100108697, 18508, 10811891.
33. Song B, Song WG, Li ZJ, Xu ZF, Wang XW, Wang CX, Liu J. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. Cell Biochem Funct 2011, 30:11-17.
34. Zhuang ZY, Xu H, Clapham DE, Ji RR. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 2004, 24:8300-8309. 10.1523/JNEUROSCI.2893-04.2004, 15385613.
35. Watson AL, Anderson LK, Greeley AD, Keng VW, Rahrmann EP, Halfond AL, Powell NM, Collins MH, Rizvi T, Moertel CL, Ratner N, Largaespada DA. Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Oncotarget 2014, 30:1502-1514.
36. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011, 18:571-580. 10.1038/cdd.2010.191, 3131912, 21311563.
37. Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D. HMGB1 promotes drug resistance in osteosarcoma. Cancer Res 2012, 72:230-238. 10.1158/0008-5472.CAN-11-2001, 22102692.
38. Tsang WP, Kwok TT. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 2009, 30:953-959. 10.1093/carcin/bgp094, 19372139.
39. Liu P, Chen L, Huang X. The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo. Cancer Biother Radiopharm 2009, 24:91-98. 10.1089/cbr.2008.0533, 19243251.
40. Hu Z, Lin D, Yuan J, Xiao T, Zhang H, Sun W, Han N, Ma Y, Di X, Gao M, Ma J, Zhang J, Cheng S, Gao Y. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin Cancer Res 2005, 11:4646-4652. 10.1158/1078-0432.CCR-04-2013, 16000556.
41. Kyrylkova K, Kyryachenko S, Leid M, Kioussi C. Detection of apoptosis by TUNEL assay. Methods Mol Biol 2012, 887:41-47. 10.1007/978-1-61779-860-3_5, 22566045.